SHC2 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Clinical signs in both FXMD-affected cats of this study were very similar to those in previously described domestic shorthair cases, with dystrophin deficiency including muscle hypertrophy as a prominent clinical feature and a markedly increased sCK activity as a clear indicator [13,14].